Cladribine and low-dose cytarabine as first salvage after hypomethylating agent and venetoclax in acute myeloid leukemia.
- DOI
- 10.1016/j.leukres.2026.108322
- Published
- 2026 Sep 19
- Container
- Leukemia research
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.leukres.2026.108322,
title = {Cladribine and low-dose cytarabine as first salvage after hypomethylating agent and venetoclax in acute myeloid leukemia.},
author = {Dutta R and Schumann C and Cheung E and Zhang TY and Ediriwickrema A and Fakhri B and Gotlib J and Liedtke M and Shomali W and Mannis GN},
year = {2026},
journal = {Leukemia research},
doi = {10.1016/j.leukres.2026.108322},
url = {https://doi.org/10.1016/j.leukres.2026.108322}
}RIS
TY - JOUR TI - Cladribine and low-dose cytarabine as first salvage after hypomethylating agent and venetoclax in acute myeloid leukemia. AU - Dutta R AU - Schumann C AU - Cheung E AU - Zhang TY AU - Ediriwickrema A AU - Fakhri B AU - Gotlib J AU - Liedtke M AU - Shomali W AU - Mannis GN PY - 2026 JO - Leukemia research DO - 10.1016/j.leukres.2026.108322 UR - https://doi.org/10.1016/j.leukres.2026.108322 ER -
APA
R, D., C, S., E, C., TY, Z., A, E., B, F., J, G., M, L., W, S., & GN, M. (2026). Cladribine and low-dose cytarabine as first salvage after hypomethylating agent and venetoclax in acute myeloid leukemia.. Leukemia research. https://doi.org/10.1016/j.leukres.2026.108322
Source records
- pubmed · retrieved 2026-09-26T07:53:30.524Z